Literature DB >> 27847365

Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.

Katayi Mwila1, Roma Chilengi2,3, Michelo Simuyandi1, Sallie R Permar4, Sylvia Becker-Dreps5.   

Abstract

The role of maternal immunity, received by infants either transplacentally or orally from breast milk, in rotavirus vaccine (RV) performance is evaluated here. Breastfeeding withholding has no effect on vaccine responses, but higher levels of transplacental rotavirus-specific IgG antibody contribute to reduced vaccine seroconversion. The gaps in knowledge on the factors associated with low RV efficacy in low- and middle-income countries (LMIC) remain, and further research is needed to shed more light on these issues.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  immunization; low- and middle-income countries; maternal; rotavirus

Mesh：

Substances：

Year:  2017        PMID： 27847365      PMCID： PMC5216432          DOI： 10.1128/CVI.00405-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  89 in total

1.  VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation.

Authors:  Jelle Matthijnssens; Peter H Otto; Max Ciarlet; Ulrich Desselberger; Marc Van Ranst; Reimar Johne
Journal:  Arch Virol       Date:  2012-03-20       Impact factor: 2.574

2.  Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection.

Authors:  M I de Moraes-Pinto; A C Almeida; G Kenj; T E Filgueiras; W Tobias; A M Santos; M M Carneiro-Sampaio; C K Farhat; P J Milligan; P M Johnson; C A Hart
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

3.  Gastric emptying in formula-fed and breast-fed infants measured with the 13C-octanoic acid breath test.

Authors:  M Van Den Driessche; K Peeters; P Marien; Y Ghoos; H Devlieger; G Veereman-Wauters
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-07       Impact factor: 2.839

4.  Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Yasutaka Hoshino; Lijuan Yuan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.

Authors:  M E Pichichero; G A Losonsky; M B Rennels; F A Disney; J L Green; A B Francis; S M Marsocci
Journal:  Pediatr Infect Dis J       Date:  1990-05       Impact factor: 2.129

6.  Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.

Authors:  Sunheang Shin; Dang Duc Anh; K Zaman; M Yunus; Le Thi Phuong Mai; Vu Dinh Thiem; Tasnim Azim; John C Victor; Michael J Dallas; A Duncan Steele; Kathleen M Neuzil; Max Ciarlet
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

7.  Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.

Authors:  Michelle G Goveia; Mark J DiNubile; Michael J Dallas; Penny M Heaton; Barbara J Kuter
Journal:  Pediatr Infect Dis J       Date:  2008-07       Impact factor: 2.129

8.  Inhibitory effects of human and bovine milk constituents on rotavirus infections.

Authors:  A S Kvistgaard; L T Pallesen; C F Arias; S López; T E Petersen; C W Heegaard; J T Rasmussen
Journal:  J Dairy Sci       Date:  2004-12       Impact factor: 4.034

9.  Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.

Authors:  Suvi Lappalainen; Ana Ruth Pastor; Maria Malm; Vanessa López-Guerrero; Fernando Esquivel-Guadarrama; Laura A Palomares; Timo Vesikari; Vesna Blazevic
Journal:  Arch Virol       Date:  2015-05-29       Impact factor: 2.574

10.  Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.

Authors:  K Zaman; Jessica A Fleming; John C Victor; Mohammad Yunus; Tajul Islam A Bari; Tasnim Azim; Mustafizur Rahman; Syed Mohammad Niaz Mowla; William J Bellini; Monica McNeal; Joseph P Icenogle; Ben Lopman; Umesh Parashar; Margaret M Cortese; A Duncan Steele; Kathleen M Neuzil
Journal:  J Infect Dis       Date:  2016-01-27       Impact factor: 5.226
View more
  16 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

2.  Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014.

Authors:  N A Page; L M Seheri; M J Groome; J Moyes; S Walaza; J Mphahlele; K Kahn; C N Kapongo; H J Zar; S Tempia; C Cohen; S A Madhi
Journal:  Vaccine       Date:  2017-10-27       Impact factor: 3.641

Review 3.  Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.

Authors:  Sumit Sharma; Johan Nordgren
Journal:  Viruses       Date:  2021-06-14       Impact factor: 5.048

4.  Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.

Authors:  Innocent Mwape; Samuel Bosomprah; John Mwaba; Katayi Mwila-Kazimbaya; Natasha Makabilo Laban; Caroline Cleopatra Chisenga; Gibson Sijumbila; Michelo Simuyandi; Roma Chilengi
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

5.  Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.

Authors:  Rebecca L Tallmadge; Steven C Miller; Stephen A Parry; Maria Julia B Felippe
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

6.  Interventions to improve oral vaccine performance: a systematic review and meta-analysis.

Authors:  James A Church; Edward P Parker; Beth D Kirkpatrick; Nicholas C Grassly; Andrew J Prendergast
Journal:  Lancet Infect Dis       Date:  2019-01-30       Impact factor: 71.421

7.  TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines.

Authors:  Irene Rivero-Calle; Jose Gómez-Rial; Louis Bont; Bradford D Gessner; Melvin Kohn; Ron Dagan; Daniel C Payne; Laia Bruni; Andrew J Pollard; Adolfo García-Sastre; Denise L Faustman; Albert Osterhaus; Robb Butler; Francisco Giménez Sánchez; Francisco Álvarez; Myrsini Kaforou; Xabier Bello; Federico Martinón-Torres
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

8.  Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting.

Authors:  James A Platts-Mills; Caroline Amour; Jean Gratz; Rosemary Nshama; Thomas Walongo; Buliga Mujaga; Athanasia Maro; Timothy L McMurry; Jie Liu; Estomih Mduma; Eric R Houpt
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

9.  Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali.

Authors:  Samba O Sow; A Duncan Steele; Jason M Mwenda; George E Armah; Kathleen M Neuzil
Journal:  Vaccine       Date:  2017-10-09       Impact factor: 3.641

10.  Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh.

Authors:  Benjamin Lee; Marya Carmolli; Dorothy M Dickson; E Ross Colgate; Sean A Diehl; Muhammad Ikhtear Uddin; Shahidul Islam; Motaher Hossain; Tanzeem Ahmed Rafique; Taufiqur Rahman Bhuiyan; Masud Alam; Uma Nayak; Josyf C Mychaleckyj; Monica M McNeal; William A Petri; Firdausi Qadri; Rashidul Haque; Beth D Kirkpatrick
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.